Atlas Trials

A Non-interventional Retrospective Study to Describe Early Clinical Experience With Cabozantinib in Patients With Advanced Renal Cell Carcinoma (RCC) in the UK

Clinical trial NCT03696407 · COMPLETED

Trial details

NCT number
NCT03696407
Sponsor
Ipsen
Status
COMPLETED
Study type
OBSERVATIONAL
Advanced Renal Cell Carcinoma
Start date
2018-12-20
Primary completion
2019-08-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.